Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway.
about
Stress hyperglycemia, insulin treatment, and innate immune cells.Diabetes is a proinflammatory state: a translational perspective.High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytesDipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.Anti-apoptotic effect of hyperglycemia can allow survival of potentially autoreactive T cellsMannose-capped Lipoarabinomannan from Mycobacterium tuberculosis induces IL-37 production via upregulating ERK1/2 and p38 in human type II alveolar epithelial cells.RNA-sequencing analysis of high glucose-treated monocytes reveals novel transcriptome signatures and associated epigenetic profilesEnhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection.Innate immunity and the pathogenesis of type 1 diabetes.Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytesSignificance of CXCL12 in type 2 diabetes mellitus and its associated complications.Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?Characterization of innate immune signalling receptors in virus-induced acute asthma.Neonatal hyperglycemia induces CXCL10/CXCR3 signaling and microglial activation and impairs long-term synaptogenesis in the hippocampus and alters behavior in rats.High glucose induces a priming effect in macrophages and exacerbates the production of pro-inflammatory cytokines after a challenge
P2860
Q33668059-6AD62BC8-AA8B-49B3-80D3-929D16C8B886Q33693974-4C8427C7-5AE4-4810-A3BC-4C2BFAF8A140Q34231913-F55E7E11-B819-4B53-9BBD-B041EB56AC53Q34597496-059F8AF9-D5DD-40DD-9E1C-B60D1442DFADQ35092646-D49D0C07-C0AD-4E39-AF78-B07C6E00EB34Q35870730-78096D69-62CA-4156-88FF-7740D18D4F0BQ36787367-4798DAA7-F2FC-4EAB-BC65-95B95CF6C815Q37713985-7BE26656-B111-491E-8246-FC03BD4F1356Q37728944-992C42D7-D100-48EF-A61C-7E397FF589EEQ38117282-C81EC2C6-386E-4A5B-8BD5-13E755D255B6Q38236202-0C5928B0-21BC-401A-A26C-91466C525A64Q42055616-B74AFCC0-BFDF-4109-99DF-5D6E29898A06Q45370832-D9C97051-8B49-47E4-81E8-F60063E1A655Q53433320-F788D77F-5A16-413D-830B-D937B42855BDQ58759014-8AAF8622-0E2E-46ED-8F4A-65558C03A2DF
P2860
Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased secretion of IP-10 f ...... via the TLR2 and TLR4 pathway.
@en
Increased secretion of IP-10 f ...... via the TLR2 and TLR4 pathway.
@nl
type
label
Increased secretion of IP-10 f ...... via the TLR2 and TLR4 pathway.
@en
Increased secretion of IP-10 f ...... via the TLR2 and TLR4 pathway.
@nl
prefLabel
Increased secretion of IP-10 f ...... via the TLR2 and TLR4 pathway.
@en
Increased secretion of IP-10 f ...... via the TLR2 and TLR4 pathway.
@nl
P2860
P1433
P1476
Increased secretion of IP-10 f ...... via the TLR2 and TLR4 pathway.
@en
P2093
Ishwarlal Jialal
Sridevi Devaraj
P2860
P356
10.1016/J.CYTO.2009.02.004
P577
2009-05-15T00:00:00Z